RE:RE:RE:RE:RE:RE:RE:Writedowns LATAMI can't give you a lot of details without outing my sources since there are only a limited amount of people that have this information.
Basically this pharma company knows the latin market very well. During merger talks the analysts viewed the LATAM assets and from what I heard they were close to Grecos number. I have no exact number ...
I'm long and didn't want this to be true, but I trust my sources